Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056328 · ClinicalTrials.gov registry record · NA
Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 324
- Enrollment target
NCT01056328 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 324 participants.
The verdict
NCT01056328, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.
Interventions
- DEVICE SJM Irrigated Cardiac Ablation System
- DEVICE FDA approved Open Irrigated RF Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2010-02 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01056328
The ClinicalTrials.gov registry entry for NCT01056328 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SJM Irrigated Cardiac Ablation System is the first listed.
NCT01056328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01056328 about?
NCT01056328 is a clinical study titled "Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)". The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.
What is the current status of trial NCT01056328?
This trial is currently completed. It is a NA study. The enrollment target is 324 participants. The study started on 2010-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01056328?
The interventions under investigation include: SJM Irrigated Cardiac Ablation System (DEVICE), FDA approved Open Irrigated RF Ablation System (DEVICE).
Who is sponsoring clinical trial NCT01056328?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.